Peptilogics Is A Clinical Stage Biotechnology Company Based In Pittsburghpafounded In 2013The Company Focuses On Peptide Therapeutic Discoveryutilizing Machine Learning And Computational Platforms To Create Innovative Treatments For Serious Diseaseswith A Team Of 28 Employees And $44 1 Million In Fundingpeptilogics Is Committed To Advancing Its Pipeline Of Anti Infective Therapies The Company Operates A Proprietary Computational Drug Discovery Platform That Accelerates The Design And Development Of Peptidesthis Platform Leverages Ai And Machine Learning To Engineer Peptides Efficientlyaddressing Challenges Associated With Traditional Methodspeptilogics Is Particularly Known For Its Ecap Technologywhich Improves The Stability And Efficacy Of Antimicrobial Peptidestargeting Serious Infections And Exploring Additional Disease Areas Led By Ceo Jonathan Steckbeckpeptilogics Employs A Recurring Revenue Modelpartnering With Clients In The Biopharmaceutical Sector To Develop Peptide Based Therapeuticsthe Company Is Focused On Scaling Its Operations And Expanding Its Therapeutic Offerings
No conferences found for this company.
| Company Name | Peptilogics Inc |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
